COVID-19: JPT receives status as Systemically Important Company

Published on 01/06/2021

The current COVID-19 outbreak and the associated lockdown have had a huge impact on our daily routines leading to uncertainties and concerns.

We are pleased to announce that German authorities have confirmed JPT’s status as a Systemically Important Institution. Thus, JPT becomes part of relevant infrastructure, as we provide critical products to the global scientific community working on treatments, vaccines and diagnostic tests for SARS-CoV-2.

In order to maintain our current status JPT Peptide Technologies has implemented measures to minimize the impact and risks to current COVID-19 pandemic product manufacturing. For the safety of our staff, we

  • Enabled as many employees as possible to work from home.
  • Implemented working in shifts to ensure a secure distance can be maintained at all times for the operational staff.
  • Created procedures in our facilities to minimize contact between team members from different departments and to external visitors.
  • Installed additional hand sanitizers and implemented strict hygiene rules.

Please contact us at any time to receive an updated status of our manufacturing capacities or reserve a slot for your research or clinical grade COVID-19 peptide needs.

We hope you and your families stay safe and healthy!

Your JPT Team

Check our list of products, click and go.

Get a quote